Stay updated on APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page.

Latest updates to the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1, with no apparent changes to the clinical study record.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe prior 403 Forbidden message and NIH transition notice are gone, replaced by a failed-fetch message and a zero count; study details remain unavailable.SummaryDifference1%

- Check21 days agoChange DetectedThe site revision shown in the footer changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedAn NIH-wide banner was added announcing updates and FAQs about the agency’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The page content otherwise remains a 403 error.SummaryDifference1%

- Check35 days agoChange DetectedThe footer's site revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error, with the footer showing revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

Stay in the know with updates to APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 vs Sham in GA: Efficacy & Safety Clinical Trial page.